Membranous Nephropathy Associated With Fluconazole Treatment

American Journal of Kidney Diseases

Volumn 49, Issue 2, 2007, Pages 318-322

  Shin, Gyu Tae ^a   Yim, Hyunee ^a   Park, Jieun ^a   Kim, Heungsoo ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

fluconazole; Membranous nephropathy; proteinuria

Indexed keywords

AMLODIPINE; FLUCONAZOLE; HYDROCHLOROTHIAZIDE; LEVOPRIDE; METOCLOPRAMIDE; SULPIRIDE; UNCLASSIFIED DRUG; VALSARTAN;

ADULT; ARTICLE; CASE REPORT; FEMALE; GENERALIZED EDEMA; HUMAN; HYPERTENSION; INDIGESTION; KIDNEY BIOPSY; MEMBRANOUS GLOMERULONEPHRITIS; NAUSEA; NEPHROTIC SYNDROME; PROTEINURIA; TINEA PEDIS; UTERINE CERVIX CANCER;

FEMALE; FLUCONAZOLE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MIDDLE AGED;

EID: 33846499132     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.11.033     Document Type: Article

References (16)

1. Cahen R., Francois B., Trolliet P., Gilly J., and Parchoux B. Aetiology of membranous glomerulonephritis: A prospective study of 82 adult patients. Nephrol Dial Transplant 4 (1989) 172-180
2. Hall C.L., Fothergill N.J., Blackwell M.M., Harrison P.R., MacKenzie J.C., and MacIver A.G. The natural course of gold nephropathy: Long term study of 21 patients. Br Med J 295 (1987) 745-748
3. Hall C.L., Jawad S., Harrison P.R., et al. Natural course of penicillamine nephropathy: A long term study of 33 patients. BMJ 296 (1988) 1083-1086
4. Campistol J.M., Galofre J., Botey A., Torras A., and Revert L. Reversible membranous nephritis associated with diclofenac. Nephrol Dial Transplant 4 (1989) 393-395
5. Radford M.G., Holley K.E., Grande J.P., et al. Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs. JAMA 276 (1996) 466-469
6. Stokes M.B., Foster K., Markowitz G.S., et al. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant 20 (2005) 1400-1406
7. Lindell A., Denneberg T., Enestrom S., Fich C., and Skogh T. Membranous glomerulonephritis induced by 2-mercaptopropionylglycine (2-MPG). Clin Nephrol 34 (1990) 108-115
8. Lesher Jr. J.L. Oral therapy of common superficial fungal infections of the skin. J Am Acad Dermatol 40 (1999) S31-S34 (suppl 6)
9. Del Aguila R., Gei F.M., Robles M., Perera-Ramirez A., and Male O. Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea pedis. Clin Exp Dermatol 17 (1992) 402-406
10. Hoorntje S.J., Donker A.J., Prins E.J., and Weening J.J. Membranous glomerulopathy in a patient on captopril. Acta Med Scand 208 (1980) 325-329
11. Nangaku M., Shankland S.J., and Couser W.G. Cellular response to injury in membranous nephropathy. J Am Soc Nephrol 16 (2005) 1195-1204
12. Romagnoli P., Spinas G.A., and Sinigaglia F. Gold-specific T cells in rheumatoid arthritis patients treated with gold. J Clin Invest 89 (1992) 254-258
13. Joh K., Shibasaki T., Azuma T., et al. Experimental drug-induced allergic nephritis mediated by antihapten antibody. Int Arch Allergy Appl Immunol 88 (1989) 337-344
14. Klouda P.T., Manos J., Acheson E.J., et al. Strong association between idiopathic membranous nephropathy and HLA-DRW3. Lancet 2 (1979) 770-771
15. Bhimma R., Hammond M.G., Coovadia H.M., Adhikari M., and Connolly C.A. HLA class I and II in black children with hepatitis B virus-associated membranous nephropathy. Kidney Int 61 (2002) 1510-1515
16. Graham A.R., and Nagle R.B. Quantitative electron microscopic study of membranous glomerulopathy. Am J Clin Pathol 80 (1983) 816-821